➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Mallinckrodt
Merck
Johnson and Johnson
Dow

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

METHOTREXATE SODIUM PRESERVATIVE FREE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Methotrexate Sodium Preservative Free patents expire, and when can generic versions of Methotrexate Sodium Preservative Free launch?

Methotrexate Sodium Preservative Free is a drug marketed by Accord Hlthcare, Hospira, Mylan Labs Ltd, Pharmachemie Bv, Sagent Pharms Inc, Sandoz Inc, and West-ward Pharms Int. and is included in thirteen NDAs.

The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Methotrexate Sodium Preservative Free

A generic version of METHOTREXATE SODIUM PRESERVATIVE FREE was approved as methotrexate sodium by WEST-WARD PHARMS INT on September 16th, 1986.

  Start Trial

Summary for METHOTREXATE SODIUM PRESERVATIVE FREE
Drug patent expirations by year for METHOTREXATE SODIUM PRESERVATIVE FREE
Recent Clinical Trials for METHOTREXATE SODIUM PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cooperative Study Group A for HematologyPhase 3

See all METHOTREXATE SODIUM PRESERVATIVE FREE clinical trials

Pharmacology for METHOTREXATE SODIUM PRESERVATIVE FREE

US Patents and Regulatory Information for METHOTREXATE SODIUM PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare METHOTREXATE SODIUM PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 040716-001 Apr 30, 2007 AP RX No Yes   Start Trial   Start Trial   Start Trial
Sandoz Inc METHOTREXATE SODIUM PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 090029-001 Mar 31, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd METHOTREXATE SODIUM PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 201529-001 Mar 29, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Baxter
McKinsey
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.